Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jinyun Su"'
Publikováno v:
All Life, Vol 15, Iss 1, Pp 262-269 (2022)
Introduction: Optic nerve gliomas (ONGs) are uncommon tumors of the central nervous system in adults. The aim of this study was to define their characteristics, prognostic factors, and the impacts of adjuvant radiotherapy (RT) and chemotherapy on out
Externí odkaz:
https://doaj.org/article/94f344f3651d4d44939f8947c8b1bd21
Publikováno v:
All Life. 15:262-269
Background: Optic nerve gliomas (ONGs) are uncommon tumors of the central nervous system in adults. The aim of this study was to define their characteristics, prognostic factors, and the impacts of adjuvant radiotherapy (RT) and chemotherapy on outco
Background: Optic nerve gliomas (ONGs) are uncommon tumors of the central nervous system in adults. The aim of this study was to define their characteristics, prognostic factors, and the impacts of adjuvant radiotherapy (RT) and chemotherapy on outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f56f29399de1f45b7ba158446e2a8ee
https://doi.org/10.21203/rs.3.rs-214021/v1
https://doi.org/10.21203/rs.3.rs-214021/v1
Autor:
Di Wu, Yong Li, Pengfei Xu, Qi Fang, Fei Cao, Hongsheng Lin, Yin Li, Yong Su, Lixia Lu, Lei Chen, Yizhuo Li, Zheng zhao, Xiaoyu Hong, Guohong Li, Yaru Tian, Jinyun Sun, Honghong Yan, Yunyun Fan, Xinrui Zhang, Zhiming Li, Xuekui Liu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Neoadjuvant chemoimmunotherapy has emerged as a potential treatment option for resectable head and neck squamous cell carcinoma (HNSCC). In this single-arm phase II trial (NCT04826679), patients with resectable locally advanced HNSCC (T2‒T
Externí odkaz:
https://doaj.org/article/cff1e650a2a04d2795418fcea6aaa310
Autor:
Caichen Li, Jun Liu, Zhanhong Xie, Feng Zhu, Bo Cheng, Hengrui Liang, Jianfu Li, Shan Xiong, Zisheng Chen, Zhichao Liu, Yi Zhao, Limin Ou, Ran Zhong, Wei Wang, Jun Huang, Jinyun Sun, Chunya Zhang, Landong Weng, Jianxing He, Wenhua Liang, Zhenkui Pan
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Programmed cell death ligand 1 (PD-L1) expression with respect to genetic alternations has not been well established in non-small cell lung cancer (NSCLC), especially in the Asian population. Methods: We reviewed 1370 NSCLC patients from
Externí odkaz:
https://doaj.org/article/c350f788dea246059d6ff9b8232382e8